ERG and prostate carcinoma: Oncogenic activation of ETS Related Gene (ERG) via chromosomal rearrangements has been well established in diverse human cancers such as Ewing sarcoma6, acute myeloid leukemia7, 8 and over half of all prostate cancers in Western countries9–12.